Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 6537 entries
Sorted by: Best Match Show Resources per page
Crinone 8%(90 mg) given once daily for progesterone replacement therapy in donor egg cycles

program design

[No authors listed]
GSID: VvxfycwuOL8J
K Jobanputra, JP Toner, R Denoncourt, WE Gibbons - Fertility and Sterility, 1999 - Elsevier

Objective: To determine whether once-daily dosing of Crinone 8%(90-mg progesterone vaginal gel; Serono Laboratories, Inc., Norwell, MA) is sufficient for normal endometrial …

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study

program design

[No authors listed]
GSID: 9Q5rCSSo0ngJ
RA Miles, RJ Paulson, RA Lobo, MF Press… - Fertility and sterility, 1994 - Elsevier

Objective To determine pharmacokinetic and endometrial effects of vaginally delivered micronized P. Design Functionally agonadal estrogen-replacement recipients received …

Experience with a novel vaginal progesterone preparation in a donor oocyte program

program design

[No authors listed]
GSID: EV0V5_oY_icJ
WE Gibbons, JP Toner, P Hamacher, P Kolm - Fertility and sterility, 1998 - Elsevier

… Objective: To compare the efficacy of a vaginal progesterone preparation with our standard IM preparation within a donor egg program. Design: Prospective randomized trial. Setting: Donor egg program at a university assisted reproductive therapy program (Jones Institute for...

Adenomyosis: current perspectives.

Obstetrics and gynecology clinics of North America

Azziz R.
PMID: 2664619
Obstet Gynecol Clin North Am. 1989 Mar;16(1):221-35.

Adenomyosis frequently involves gravid and nongravid uteri, remaining asymptomatic in up to one half of all cases. The symptoms of adenomyosis, particularly menorrhagia and dysmenorrhea, correlated with the depth of myometrial involvement, and consequently with the patient's age. Adenomyosis...

Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

OncoTargets and therapy

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
PMID: 24124381
Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013.

Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that...

Expression of e-cadherin, leukemia inhibitory factor and progesterone receptor in mouse blastocysts after ovarian stimulation.

Cell journal

Movaghar B, Askarian S.
PMID: 23508459
Cell J. 2012;14(3):225-30. Epub 2012 Dec 12.

OBJECTIVE: The appropriate interaction between a blastocyst and the endometrium is essential for successful implantation. Numerous factors, including hormone receptors (progesterone receptor), cytokines [leukemia inhibitory factors (LIF)], and adherence molecules such as E-cadherin are involved in the cross-talk that...

Affinity of estrogens for human progesterone receptor A and B monomers and risk of breast cancer: a comparative molecular modeling study.

Advances and applications in bioinformatics and chemistry : AABC

Hasan TN, B LG, Masoodi TA, Shafi G, Alshatwi AA, Sivashanmugham P.
PMID: 21918635
Adv Appl Bioinform Chem. 2011;4:29-36. doi: 10.2147/AABC.S17371. Epub 2011 Mar 08.

BACKGROUND: The human progesterone receptor (hPR) belongs to the steroid receptor family. It may be found as monomers (A and B) and or as a dimer (AB). hPR is regarded as the prognostic biomarker for breast cancer. In a...

Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer.

SpringerPlus

Pinto AE, Areia F, Pereira T, Cardoso P, Aparício M, Silva GL, Ferreira MC, André S.
PMID: 24010033
Springerplus. 2013 Aug 09;2:375. doi: 10.1186/2193-1801-2-375. eCollection 2013.

BACKGROUND: Accurate assessment of estrogen (ER) and progesterone (PR) receptors is critical in predicting the response to endocrine therapies in breast cancer.MATERIAL AND METHODS: From a series of 360 patients with breast invasive carcinoma assessed for hormone receptors by...

The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells.

Iranian journal of basic medical sciences

Hassanzadeh P, Arbabi E.
PMID: 23493386
Iran J Basic Med Sci. 2012 Sep;15(5):1046-52.

OBJECTIVES: Progesterone is a steroid hormone whose biology has been greatly studied within the confines of reproductive function. In recent years, the neuroprotective effects of progesterone have attracted growing interest. Glial cell line-derived neurotrophic factor (GDNF), is a neurotrophic...

Past, present, and future of hormonal therapy in recurrent endometrial cancer.

International journal of women's health

Carlson MJ, Thiel KW, Leslie KK.
PMID: 24833920
Int J Womens Health. 2014 May 02;6:429-35. doi: 10.2147/IJWH.S40942. eCollection 2014.

Endometrial cancer is a heterogeneous disease. Type I cancers are hormonally driven, typically present with a low grade at an early stage, and are of endometrioid histology. These cancers are often cured by surgery, and the rate of recurrence...

Asymptotics of nonparametric L-1 regression models with dependent data.

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability

Zhao Z, Wei Y, Lin DK.
PMID: 24955016
Bernoulli (Andover). 2014 Aug 01;20(3):1532-1559. doi: 10.3150/13-BEJ532.

We investigate asymptotic properties of least-absolute-deviation or median quantile estimates of the location and scale functions in nonparametric regression models with dependent data from multiple subjects. Under a general dependence structure that allows for longitudinal data and some spatially...

Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age.

Journal of equine science

Dhakal P, Tsunoda N, Nakai R, Nagaoka K, Nambo Y, Sato F, Taniyama H, Taya K.
PMID: 24833982
J Equine Sci. 2011;22(1):9-15. doi: 10.1294/jes.22.9. Epub 2011 Apr 26.

The aim of present study was to clarify the post-natal profile of follicle-stimulating hormone (FSH), luteinizing hormone (LH), immunoreactive (ir)-inhibin, progesterone, testosterone, and estradiol-17β, and their relationships in Thoroughbred colts. Six hundred and thirty-six colts were used for the...

Showing 1 to 12 of 6537 entries